Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: A family-based study

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 105, Issue 5, 2001, Pages 464-470

  Payton, Antony ^a   Holmes, Jane ^b   Barrett, Jennifer H ^a   Hever, Tracey ^b   Fitzpatrick, Helen ^b   Trumper, Anne L ^b   Harrington, Richard ^b   McGuffin, Peter ^c   O'Donovan, Michael ^d   Owen, Michael ^d   Ollier, William ^a   Worthington, Jane ^a   Thapar, Anita ^b,d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^c Social Genetic and Developmental Psychiatry Centre   (United Kingdom)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Association study; Attention deficit hyperactivity disorder; Genetics; Kyperkinetic disorder

Indexed keywords

DOPAMINE; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DNA POLYMORPHISM; DOPAMINE METABOLISM; GENETIC ASSOCIATION; GENETICS; GENOTYPE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADOLESCENT; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CATECHOL O-METHYLTRANSFERASE; CHILD; DNA; DOPAMINE; DOPAMINE BETA-HYDROXYLASE; FAMILY HEALTH; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; MALE; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; RECEPTORS, DOPAMINE D5; SIGNAL TRANSDUCTION; TYROSINE 3-MONOOXYGENASE;

EID: 0035827829     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.1407     Document Type: Article

References (30)

1. Neurotransmitter transporters: Recent progress
2. The child and adolescent psychiatric assessment
3. Linkage study of catechol-o-methyltransferase and attention-deficit hyperactivity disorder
4. Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention deficit hyperactivity disorder
5. Attention-deficit hyperactivity disorder and the gene for the dopamine D5 receptor
6. Further evidence from haplotype analysis for linkage of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder
7. Dinucleotide repeat polymorphism at the MAOA locus
8. Genomewide transmission/disequilibrium testing: Consideration of the genotypic relative risks at disease loci
9. Mission: Not impossible? candidate gene studies in child psychiatric disorders
10. Population genetics of a functional variant of the dopamine βhydroxylase gene (DBH)
11. Mapping susceptibility loci in attention deficit hyperactivity disorder; preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children
12. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): Association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype
13. Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder
14. Meta-analysis of the association between the dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder
15. No association between catechol-o-methyltransferase (COMT) gene polymorphism and attention deficit hyper activity disorder (ADHD) in an Irish sample
16. A family-based and case control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder
17. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders
18. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders
19. A genetic polymorphism in the promotor region of DRD4 associated with expression and schizophrenia
20. Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH)
21. An extended transmission/disequilibrium test (ETDT) for multi-allele marker loci
22. Cloning of the human dopamine D5 receptor gene and identification of a highly polymorphic microsatellite for the DRD5 locus that shows tight linkage to the chromosome 4p reference marker Rafp1
23. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)
24. No association between low- and high-activity catecholamine-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children
25. Syndromes of attention deficit and overactivity
26. Degenerate oligonucleotide-orimed PCR: General amplification of target
27. Genetic basis of attention deficit and hyperactivity
28. Structure and function of dopamine receptors
29. The neurobiology of attention-deficit/hyperactivity disorder